CD44 and central nervous system cancer: In spite this tendency of glioma stem cells to exhibit a proneural signature, some glioma stem lines preferentially express mesenchymal markers: the mesenchymal stem cell lines are CD44+, exhibit low CD15 and OLIG2 expression and are characterized by a high radioresistance [89].